先天免疫系统
下调和上调
神经退行性变
基因敲除
细胞生物学
干扰素基因刺激剂
免疫系统
干扰素
胞浆
生物
癌症研究
信号转导
RNA干扰
线粒体
神经科学
DNA损伤
化学
细胞凋亡
RNA沉默
Ⅰ型干扰素
神经毒性
作者
Marcel Naumann,Theresa M. Wierschin,Stefanie Kretschmer,Banaja P. Dash,Aaron Held,Andrea Salzinger,Kevin Peikert,Anže Karlek,Hannes Glaß,Dajana Großmann,René Günther,Susanne Petri,Annekathrin Rödiger,Dávid Brenner,Francisco J. Pan-Montojo,Eleonora Aronica,Markus Kipp,Vitaly L. Zimyanin,Jared L. Sterneckert,Torsten Grehl
标识
DOI:10.1002/advs.202417135
摘要
Recent research demonstrated activation of the innate immune system in ALS models. This pathway can be activated by cGAS‐STING sensing of cytosolic DNA that accumulates as a result of chronic DNA damage and defective mitochondria, both of which was identified as pathology in FUS‐ALS. Therefore, we analyzed innate immune pathways in FUS‐ALS, which revealed upregulation of interferon‐stimulated genes (ISGs) and activation of the TBK1‐IRF3 pathway in FUS mut iPSC‐derived spinal motor neurons (sMNs). Accumulation of cytosolic dsRNA and its sensor RIG‐I, but not MDA5, was found to be significantly upregulated in FUS mut sMNs, which was abolished upon siRNA‐mediated knockdown of RIG‐I. RIG‐I was highly expressed in FUS‐ALS post‐mortem α‐MNs. IFN treatment of FUS wt sMNs phenocopied the axonal degeneration of FUS mut sMNs. Mitochondrial transcription, a known source of dsRNA, was found to be upregulated in compartmental axonal RNAseq analysis and its inhibition reduced ISGs in FUS‐ALS sMNs. The JAK‐STAT inhibitor ruxolitinib alleviated the upregulated ISG expression and reversed the axonal degeneration of sMNs. Finally, we analyzed ISG expression in peripheral blood from 18 FUS‐ALS patients, eight of whom had a significantly elevated interferon signature. RIG‐I‐mediated innate immune activation in sMNs may be an interesting novel individualized biomarker‐driven therapeutic target in (FUS‐) ALS. A one‐sentence summary of your paper : RIG‐I‐mediated innate immune activation is found in FUS‐ALS spinal motor neurons caused by cytosolic dsRNA accumulation due to mitochondrial transcriptional activation and is amenable to JAK‐STAT inhibition and might thus be an interesting novel individualized biomarker‐driven therapeutic approach in (FUS‐) ALS.
科研通智能强力驱动
Strongly Powered by AbleSci AI